Literature DB >> 7892457

Gianturco stent placement in malignant caval obstruction: analysis of factors for predicting the outcome.

S Furui1, S Sawada, K Kuramoto, Y Inoue, T Irie, K Makita, T Yamauchi, K Tsuchiya, S Kusano.   

Abstract

PURPOSE: To determine the factors that may be used to predict outcome of stent placement in patients with malignancies obstructing the superior or inferior vena cava.
MATERIALS AND METHODS: Gianturco stents were placed in 39 patients with malignant obstruction of the superior (n = 16) or inferior (n = 23) vena cava. Thirteen patients with obstruction of the superior vena cava received radiation therapy and/or chemotherapy at some time in their course of treatment. Computed tomographic (CT) scans were obtained in all patients. The authors analyzed treatment outcome with the location, length, and CT appearance of obstruction.
RESULTS: Venous congestive symptoms disappeared after stent placement in 35 patients and remained in four. Symptoms did not recur during 1-13-month follow-up in 32 of the 35 patients in whom the symptoms disappeared. Nonfatal complications were observed in nine patients. Results of multivariate analysis showed that the outcome of stent placement is best predicted by the appearance of obstructions on CT scans irrespective of the location and length of the lesions.
CONCLUSION: Good results can be expected from placement of Gianturco stents except when CT shows the obstruction to be totally enveloped by tumor.

Entities:  

Mesh:

Year:  1995        PMID: 7892457     DOI: 10.1148/radiology.195.1.7892457

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  6 in total

1.  Gianturco Z-stent placement for the treatment of chronic central venous occlusive disease: implantation of 208 stents in 137 symptomatic patients.

Authors:  Joseph L McDevitt; Daryl T Goldman; Jacob J Bundy; Anthony N Hage; Neil K Jairath; Joseph J Gemmete; Ravi N Srinivasa; Jeffrey Forris Beecham Chick
Journal:  Diagn Interv Radiol       Date:  2021-01       Impact factor: 2.630

2.  Endoluminal treatment for venous vascular complications of malignant tumors.

Authors:  Liang Xiao; Jia-Jie Tong; Jing Shen
Journal:  Exp Ther Med       Date:  2012-05-24       Impact factor: 2.447

Review 3.  Superior Vena Cava Syndrome: Etiologies, Manifestations, and Treatments.

Authors:  Keith B Quencer
Journal:  Semin Intervent Radiol       Date:  2022-08-31       Impact factor: 1.780

Review 4.  Superior vena cava syndrome.

Authors:  L J Wudel; J C Nesbitt
Journal:  Curr Treat Options Oncol       Date:  2001-02

5.  Covered stent placement for the treatment of malignant superior vena cava syndrome: is unilateral covered stenting safe and effective?

Authors:  Younghoon Cho; Dong Il Gwon; Gi-Young Ko; Heung Kyu Ko; Jin Hyoung Kim; Ji Hoon Shin; Hyun-Ki Yoon; Kyu-Bo Sung
Journal:  Korean J Radiol       Date:  2014-01-08       Impact factor: 3.500

6.  A retrospective stenting study on superior vena cava syndrome caused by lung cancer.

Authors:  Sen Wei; Jinghao Liu; Xin Li; Zuoqing Song; Ming Dong; Honglin Zhao; Qingchun Zhao; Gang Chen; Jun Chen
Journal:  Thorac Cancer       Date:  2020-05-21       Impact factor: 3.500

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.